Ticker

Analyst Price Targets — BNGO

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
May 20, 2025 11:53 amJason McCarthyMaxim Group$8.00$3.77TheFly Bionano Genomics upgraded to Buy from Hold at Maxim
August 28, 2024 6:51 amSung Ji NamScotiabank$1.00$0.51TheFly Bionano Genomics downgraded at Scotiabank on limited capital market visibility
May 16, 2024 4:45 amMark MassaroBTIG$2.00$1.15StreetInsider Bionano Genomics (BNGO) PT Lowered to $2 at BTIG
May 25, 2023 2:47 pmBionano Genomics'sEF Hutton$175.00$65.00Benzinga Bionano Genomics' Next-Gen Platform Set to Boost Throughput by 13x: Future of Cytogenetic Analysis Underway
December 12, 2022 8:34 amBTIG$350.00$219.00Benzinga BTIG Assumes Bionano Genomics at Buy, Announces Price Target of $3.5

Latest News for BNGO

Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma

SAN DIEGO, April 02, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced the publication of a study in the American Journal of Hematology demonstrating that optical genome mapping (OGM) can significantly outperform traditional analytical methods for detection of structural variations and chromosomal abnormalities in multiple myeloma (MM), a complex hematologic malignancy known for its low…

GlobeNewsWire • Apr 2, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for BNGO.

No House trades found for BNGO.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top